Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial

BACKGROUND: Although almost a year has passed since the Coronavirus disease 2019 (COVID-19) outbreak and promising reports of vaccines have been presented, we still have a long way until these measures are available for all. Furthermore, the most appropriate corticosteroid and dose in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranjbar, Keivan, Moghadami, Mohsen, Mirahmadizadeh, Alireza, Fallahi, Mohammad Javad, Khaloo, Vahid, Shahriarirad, Reza, Erfani, Amirhossein, Khodamoradi, Zohre, Gholampoor Saadi, Mohammad Hasan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035859/
https://www.ncbi.nlm.nih.gov/pubmed/33838657
http://dx.doi.org/10.1186/s12879-021-06045-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035859/
https://www.ncbi.nlm.nih.gov/pubmed/33838657
http://dx.doi.org/10.1186/s12879-021-06045-3

Ejemplares similares